about
Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients.Serum osteopontin level correlates with carotid-femoral pulse wave velocity in geriatric personsHigh Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease.Triceps Skinfold Thickness Is Associated With Lumbar Bone Mineral Density in Peritoneal Dialysis Patients.Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome.Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease.Serum cystatin C is independently associated with aortic arterial stiffness in patients with type 2 diabetes.Association between hyperleptinemia and cardiovascular outcomes in patients with coronary artery diseaseInverse Association of N-terminal Pro‒B-type Natriuretic Peptide Level With Metabolic Syndrome in Kidney Transplant PatientsDevelopment and validation of a nomogram for urothelial cancer in patients with chronic kidney diseaseAngiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patientsSerum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional studySerum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease PatientsLower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis PatientsSerum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 DiabetesCorrelation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional studyAssociation between Serum Indoxyl Sulfate Levels and Endothelial Function in Non-Dialysis Chronic Kidney DiseaseMetabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease PatientsAcute Kidney Injury and Septic Shock-Defined by Updated Sepsis-3 Criteria in Critically Ill PatientsSerum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney diseaseHigh-Serum Angiopoietin-Like Protein 3 Levels Associated with Cardiovascular Outcome in Patients with Coronary Artery DiseaseSerum P-Cresyl Sulfate Is a Predictor of Central Arterial Stiffness in Patients on Maintenance HemodialysisSerum Adipocyte Fatty Acid-Binding Protein Level is Negatively Associated with Vascular Reactivity Index Measured by Digital Thermal Monitoring in Kidney Transplant PatientsHigh serum adipocyte fatty acid binding protein concentration linked with increased aortic arterial stiffness in patients with type 2 diabetesPositive Association of Serum Adipocyte Fatty Acid Binding Protein Level With Peripheral Artery Disease in Hemodialysis PatientsAssociation of Low Serum l-Carnitine Levels with Peripheral Arterial Stiffness in Patients Who Undergo Kidney TransplantationAssociation of Low Serum Adiponectin Levels with Aortic Arterial Stiffness in Patients with Type 2 DiabetesSerum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients
P50
Q33851063-E6FEC13A-F4FA-4C85-9997-38C96E14F710Q34009369-4FF4B6B4-ECCE-412D-9665-191D269E4280Q37497167-06325474-0DF1-4EF6-BC00-7379968A998CQ38642771-7F7E1D34-FBB7-41E6-921A-F68DA90818E8Q39243747-801C7F1C-E524-4872-9752-F52AC8A4209CQ45012352-6DEEB8C9-5374-4565-B192-A0A1423239CFQ47874454-B65686FE-F45D-4843-AF38-E9D6B7C61443Q50024991-AE9B3D95-5C95-4A2B-840D-9F45B9644AE1Q50061059-0ACE3ED0-D647-4B2D-A2A6-6D665F5FAF4DQ57489136-1D807CC0-8114-4ABE-BE71-AE1B82AF27F7Q57489259-2AAC6A38-998F-4523-8F0E-FD52B5415A8FQ64065067-94E0F588-55BB-4B7C-BA15-F1FA55DDF83CQ64246020-D5076B83-A5FD-4B15-A286-96961AEF8B63Q64281719-00E4B3BB-0BE2-45D8-B976-470A056520D4Q89781946-792C8F29-B9EE-462A-9BCF-3FB484A0979CQ90433318-A0056287-2F10-4326-9818-BE4B05907509Q90469161-C0052A91-656A-4372-9E3F-65EDF6CF65FFQ90473037-162C3E25-EACE-4004-9CB6-8FEA5667BFEEQ90721116-6D507D71-4469-45CC-9BF7-55125B5791B6Q90835399-0B5917F0-EF15-454D-9B61-22331110C0BCQ90853037-2A915D3A-F90A-4A0D-A878-BB5CA58400E5Q91301529-612F314C-9609-49F3-AF20-98E744A04530Q91842705-0D975BA4-8F29-470E-9D3B-16DD22E3AB80Q92255525-A2ED750B-9497-40E6-95F9-26DE2B4CB430Q92343921-9670BBEE-C83B-4031-A07D-1E0345D9A1BBQ92718426-31C10228-5247-4588-B6B9-CB1327E0AA5AQ92748420-B39F1746-D855-4687-ABB2-E3AF17492C81Q92874299-88185B0E-7628-481E-97EE-219E96B86295Q92989238-A357BF99-4CA5-40E2-85AD-2CA314814552Q94667773-AF5C7BC1-26F7-4CAC-A589-E88BAFD39739Q96605534-0B2049AA-C610-4F1C-AFE0-40DAFCF8AAE6
P50
description
researcher
@en
wetenschapper
@nl
name
Bang-Gee Hsu
@en
Bang-Gee Hsu
@nl
type
label
Bang-Gee Hsu
@en
Bang-Gee Hsu
@nl
prefLabel
Bang-Gee Hsu
@en
Bang-Gee Hsu
@nl
P31
P496
0000-0001-9364-4558